OBJECTIVE: To examine the relationship between inflammation and posttraumatic arthritis (PTA) in a murine intraarticular fracture model. METHODS: Male C57BL/6 and MRL/MpJ "superhealer" mice received tibial plateau fractures using a previously established method. Mice were killed on day 0 (within 4 hours of fracture) and days 1, 3, 5, 7, 28, and 56 after fracture. Synovial tissue samples, obtained prior to fracture and on days 0, 1, 3, 5, and 7 after fracture, were examined by reverse transcription-polymerase chain reaction for gene expression of proinflammatory cytokines and chemokines. Synovial fluid and serum samples were collected to measure cytokine concentrations, using enzyme-linked immunosorbent assay. Whole joints were examined histologically for the extent of synovitis and cartilage degradation, and joint tissue samples from all time points were analyzed immunohistochemically to evaluate the distribution of interleukin-1 (IL-1). RESULTS: Compared to C57BL/6 mice, MRL/MpJ mice had less severe intraarticular and systemic inflammation following joint injury, as evidenced by lower gene expression of tumor necrosis factor α and IL-1β in the synovial tissue and lower protein levels of IL-1α and IL-1β in the synovial fluid, serum, and joint tissues. Furthermore, after joint injury, MRL/MpJ mice had lower gene expression of macrophage inflammatory proteins and macrophage-derived chemokine (CCL22) in the synovial tissue, and also had reduced acute and late-stage infiltration of synovial macrophages. CONCLUSION: C57BL/6 mice exhibited higher levels of inflammation than MRL/MpJ mice, indicating that MRL/MpJ mice are protected from PTA in this model. These data thus suggest an association between joint tissue inflammation and the development and progression of PTA in mice.
OBJECTIVE: To examine the relationship between inflammation and posttraumatic arthritis (PTA) in a murineintraarticular fracture model. METHODS: Male C57BL/6 and MRL/MpJ "superhealer" mice received tibial plateau fractures using a previously established method. Mice were killed on day 0 (within 4 hours of fracture) and days 1, 3, 5, 7, 28, and 56 after fracture. Synovial tissue samples, obtained prior to fracture and on days 0, 1, 3, 5, and 7 after fracture, were examined by reverse transcription-polymerase chain reaction for gene expression of proinflammatory cytokines and chemokines. Synovial fluid and serum samples were collected to measure cytokine concentrations, using enzyme-linked immunosorbent assay. Whole joints were examined histologically for the extent of synovitis and cartilage degradation, and joint tissue samples from all time points were analyzed immunohistochemically to evaluate the distribution of interleukin-1 (IL-1). RESULTS: Compared to C57BL/6 mice, MRL/MpJ mice had less severe intraarticular and systemic inflammation following joint injury, as evidenced by lower gene expression of tumor necrosis factor α and IL-1β in the synovial tissue and lower protein levels of IL-1α and IL-1β in the synovial fluid, serum, and joint tissues. Furthermore, after joint injury, MRL/MpJ mice had lower gene expression of macrophage inflammatory proteins and macrophage-derived chemokine (CCL22) in the synovial tissue, and also had reduced acute and late-stage infiltration of synovial macrophages. CONCLUSION: C57BL/6 mice exhibited higher levels of inflammation than MRL/MpJ mice, indicating that MRL/MpJ mice are protected from PTA in this model. These data thus suggest an association between joint tissue inflammation and the development and progression of PTA in mice.
Authors: T Matsui; T Akahoshi; R Namai; A Hashimoto; Y Kurihara; M Rana; A Nishimura; H Endo; H Kitasato; S Kawai; K Takagishi; H Kondo Journal: Clin Exp Immunol Date: 2001-07 Impact factor: 4.330
Authors: A Katrib; P P Tak; J V Bertouch; C Cuello; H P McNeil; T J Smeets; M C Kraan; P P Youssef Journal: Rheumatology (Oxford) Date: 2001-09 Impact factor: 7.580
Authors: J M Leferovich; K Bedelbaeva; S Samulewicz; X M Zhang; D Zwas; E B Lankford; E Heber-Katz Journal: Proc Natl Acad Sci U S A Date: 2001-08-07 Impact factor: 11.205
Authors: Farshid Guilak; Beverley Fermor; Francis J Keefe; Virginia B Kraus; Steven A Olson; David S Pisetsky; Lori A Setton; J Brice Weinberg Journal: Clin Orthop Relat Res Date: 2004-06 Impact factor: 4.176
Authors: A Nair; J Gan; C Bush-Joseph; N Verma; M W Tetreault; K Saha; A Margulis; L Fogg; C R Scanzello Journal: Osteoarthritis Cartilage Date: 2015-02-24 Impact factor: 6.576
Authors: Steven A Olson; Bridgette D Furman; Virginia B Kraus; Janet L Huebner; Farshid Guilak Journal: J Orthop Res Date: 2015-06-07 Impact factor: 3.494
Authors: B A Christiansen; F Guilak; K A Lockwood; S A Olson; A A Pitsillides; L J Sandell; M J Silva; M C H van der Meulen; D R Haudenschild Journal: Osteoarthritis Cartilage Date: 2015-05-21 Impact factor: 6.576
Authors: B Moradi; N Rosshirt; E Tripel; J Kirsch; A Barié; F Zeifang; T Gotterbarm; S Hagmann Journal: Clin Exp Immunol Date: 2015-04 Impact factor: 4.330
Authors: K A Kimmerling; B D Furman; D S Mangiapani; M A Moverman; S M Sinclair; J L Huebner; A Chilkoti; V B Kraus; L A Setton; F Guilak; S A Olson Journal: Eur Cell Mater Date: 2015-01-31 Impact factor: 3.942
Authors: Josef A Stolberg-Stolberg; Bridgette D Furman; N William Garrigues; Jaewoo Lee; David S Pisetsky; Nancy A Stearns; Louis E DeFrate; Farshid Guilak; Steven A Olson Journal: J Orthop Res Date: 2013-04-25 Impact factor: 3.494
Authors: Bridgette D Furman; Collin L Kent; Janet L Huebner; Virginia B Kraus; Amy L McNulty; Farshid Guilak; Steven A Olson Journal: J Orthop Res Date: 2017-11-20 Impact factor: 3.494